Pacer Advisors, Inc. Incyte Corp Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 16,460 shares of INCY stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,460

Previous 2,692,182 99.39%

Holding current value

$1.17 Million

Previous $163 Million 99.33%

% of portfolio

0.0%

Previous 0.42%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$57.33 - $68.61 $153 Million - $184 Million	-2,675,722 Reduced 99.39%	16,460 $1.09 Million
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $137 Million - $171 Million	2,676,851 Added 17460.38%	2,692,182 $163 Million
Q1 2024 May 10, 2024	SELL	$56.55 - $66.59 $57.1 Million - $67.3 Million	-1,010,453 Reduced 98.51%	15,331 $873,000
Q4 2023 Jan 16, 2024	BUY	$52.16 - $64.19 $51.7 Million - $63.6 Million	991,110 Added 2858.37%	1,025,784 $64.4 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $887,924 - $1.01 Million	15,370 Added 79.62%	34,674 $2 Million
Q2 2023 Jul 12, 2023	SELL	$60.95 - $75.51 $45.3 Million - $56.1 Million	-743,145 Reduced 97.47%	19,304 $1.2 Million
Q1 2023 May 02, 2023	BUY	$70.23 - $86.01 $53.5 Million - $65.5 Million	761,783 Added 114381.83%	762,449 $55.1 Million
Q4 2022 Feb 06, 2023	SELL	$67.18 - $84.11 $533,745 - $668,253	-7,945 Reduced 92.27%	666 $53,000
Q3 2022 Oct 18, 2022	SELL	$66.18 - $82.86 $7,279 - $9,114	-110 Reduced 1.26%	8,611 $574,000
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $64,128 - $80,601	-969 Reduced 10.0%	8,721 $663,000
Q1 2022 Apr 05, 2022	SELL	$66.02 - $79.71 $5,941 - $7,173	-90 Reduced 0.92%	9,690 $770,000
Q4 2021 Feb 03, 2022	SELL	$63.34 - $74.11 $1.02 Million - $1.2 Million	-16,130 Reduced 62.25%	9,780 $718,000
Q3 2021 Oct 15, 2021	BUY	$68.67 - $84.02 $167,074 - $204,420	2,433 Added 10.36%	25,910 $1.78 Million
Q2 2021 Jul 21, 2021	BUY	$79.87 - $87.53 $438,007 - $480,014	5,484 Added 30.48%	23,477 $1.98 Million
Q1 2021 Apr 05, 2021	SELL	$76.02 - $100.5 $155,156 - $205,120	-2,041 Reduced 10.19%	17,993 $1.46 Million
Q4 2020 Jan 20, 2021	SELL	$80.74 - $97.7 $1.14 Million - $1.37 Million	-14,064 Reduced 41.25%	20,034 $1.74 Million
Q3 2020 Oct 19, 2020	SELL	$85.07 - $109.69 $278,859 - $359,563	-3,278 Reduced 8.77%	34,098 $3.06 Million
Q2 2020 Jul 29, 2020	BUY	$74.18 - $108.93 $1.48 Million - $2.17 Million	19,897 Added 113.83%	37,376 $3.89 Million
Q1 2020 Apr 23, 2020	BUY	$63.18 - $85.97 $32,348 - $44,016	512 Added 3.02%	17,479 $1.75 Million
Q4 2019 Feb 10, 2020	SELL	$73.04 - $95.72 $1.41 Million - $1.85 Million	-19,321 Reduced 53.24%	16,967 $1.48 Million
Q3 2019 Oct 10, 2019	BUY	$72.82 - $86.52 $286,765 - $340,715	3,938 Added 12.17%	36,288 $2.69 Million
Q2 2019 Aug 12, 2019	BUY	$73.52 - $88.7 $342,309 - $412,987	4,656 Added 16.81%	32,350 $2.75 Million
Q1 2019 Apr 10, 2019	BUY	$63.56 - $88.17 $1.76 Million - $2.44 Million	27,694 New	27,694 $2.38 Million
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $1.25 Million - $1.49 Million	-21,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $398,843 - $479,451	6,459 Added 43.52%	21,300 $1.47 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $160,644 - $221,707	2,640 Added 21.64%	14,841 $994,000
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $119,108 - $144,805	1,434 Added 13.32%	12,201 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $251,115 - $312,954	2,684 Added 33.21%	10,767 $1.02 Million
Q3 2017 Nov 08, 2017	BUY	$109.15 - $138.27 $882,259 - $1.12 Million	8,083	8,083 $944,000

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Incyte Corp Transaction History